Anti-malarial Drugs Market Size 2022 Global Opportunities, Trends, Share, Regional Overview, Global Growth, and Country Forecast

 



  Malaria is an infectious disease spread by the bite of an infected female Anopheles mosquito, which transmits parasites into the human body. Furthermore, these parasites enter liver cells and multiply and grow there. They then progress to the red blood cell stage, where they are known as merozoites. These merozoites grow inside red cells and destroy them, resulting in symptoms like fever, tiredness, vomiting, and headache. Furthermore, antimalarial drugs are those that are used to treat and prevent malarial infections. For the treatment of malarial infection, various drugs are available on the market, including quinine, chloroquine, proguanil, mefloquine, pyrimethamine, and others.

  The rise in malaria prevalence in developing countries is a major factor driving the growth of the anti-malarial drugs market. Furthermore, increased government awareness initiatives and increased research for new antimalarial drugs are some of the factors driving the market growth. However, in developing countries, a lack of awareness about healthcare is a major factor impeding the growth of the anti-malarial drugs market. Conversely, emerging economies' growth opportunities are expected to provide lucrative opportunities for market expansion during the forecast period.

  Malaria infections are treated and prevented with antimalarial drugs. Human malaria is caused by five different types of plasmodia parasites. Malaria is found in over 100 countries, primarily in the world's tropical regions, which include Central and South America, Africa, Asia, the Middle East, and some Pacific islands. Malaria medication and treatment duration are determined by the type of malaria and the severity of symptoms. The majority of antimalarial medications target the stage of infection that causes symptomatic illness.

  Pfizer, GlaxoSmithKline Plc., Ranbaxy Laboratories, Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Novartis AG, Alvizia Health Care, Bayer AG, and Roche Inc. are some of the major market players in the global anti-malarial drugs market.



Paperblog

Comments

Popular posts from this blog

Snack Product Market investigation development interest, central members, share size, and estimate to 2026

Healthcare M2M market How the Market Will Witness generous Growth and Comprehensive Evaluation Of The Market in the Upcoming years

Digital Radiography Market Analysis and Value Chain Study Forecast to 2028 | Siemens, Allengers Medical Systems, Fujifilm Hilding